Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Maternal Serum Triple Test

Screening for ALPHA-FETOPROTEIN; HUMAN CHORIONIC GONADOTROPIN; and unconjugated ESTRIOL in a pregnant woman's sera.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Risk for foetal Down syndrome (DS) increases as maternal age increases. Non‐invasive screening (maternal serum triple test) for… Expand
Is this relevant?
2015
2015
BackgroundA primary goal of amniocentesis is the detection of trisomy 21 (Down syndrome- DS) in the fetus. This procedure… Expand
  • table 2
Is this relevant?
2011
2011
AIM The purpose of this article was to evaluate the reliability of maternal serum triple marker screening of alpha-fetoprotein… Expand
Is this relevant?
2010
2010
The effectiveness of serologic and echographic non-invasive prenatal screening (IPS) in identifying pregnant women at increased… Expand
Is this relevant?
2008
2008
A 32‐year‐old woman at 17 weeks of gestation had a high possibility (1:82) of having a child with Down syndrome. Fetal chromosome… Expand
Is this relevant?
Review
2007
Review
2007
In the early 1990s Nicolaides introduced screening for trisomy 21 by fetal nuchal translucency thickness measurement with… Expand
Is this relevant?
2004
2004
Hypophosphatasia is a rare heritable inborn error of metabolism characterized by a liver/bone/kidney alkaline phosphatase… Expand
Is this relevant?
2002
2002
In a previous retrospective study on the physical and psychomotor development of 868 children born after positive maternal serum… Expand
Is this relevant?